Autres langues Aiforia Technologies Oyj

Actions

AIFORIA

FI4000507934

Marché Fermé - Nasdaq Helsinki Autres places de cotation 17:23:08 29/04/2024			Pré-ouverture 08:03:23
3,91 ^EUR	-1,51 %		3,94	+0,77 %

09/04	Aiforia Technologies Oyj nomme Richard Haworth à son conseil scientifique	CI
07/03	Aiforia Technologies Oyj publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board	09/04
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow	06/03
Aiforia Technologies Plc updates its short and mid-term business targets	19/01
Aiforia Partners with US Nonprofit to Commercialize AI Predicting Colorectal Cancer Recurrence	02/01
Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence	02/01
Aiforia Signs a Licensing Agreement with the Mayo Clinic for an AI Model That Improves Prediction of Colorectal Cancer Recurrence	02/01
Aiforia Technologies Enters Three-year Technology Deal with Italian Hospital	27/12
Aiforia Signs A Deal with an Italian Hospital in Catania	27/12
Aiforia signs a deal with an Italian hospital in Catania	27/12
Share subscriptions based on stock options 2016A	22/12
Aiforia Technologies Plc - Managers' Transactions	19/12
Professor Inti Zlobec joins Aiforia's Scientific Advisory Board	08/12
Aiforia Technologies Oyj Announces Appointment of Professor Inti Zlobec to Its Scientific Advisory Board	08/12
Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2024	04/12
Change in Aiforia Technologies Plc's Management Team	01/12
Aiforia Technologies plc Appoints Panu Kauppila as Chief Product Officer and A Member of the Management Team	01/12
Aiforia's transition to IFRS reporting	01/12
Aiforia initiates path to secure its first regulatory approval in the United States - application to the FDA anticipated in 2024	20/10/23
Aiforia Technologies Plc Initiates Path to Secure its First Regulatory Approval in the United States	20/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Aiforia Technologies Oyj

Actions

AIFORIA

FI4000507934

Autres langues

Filtres